Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-18-014461
Filing Date
2018-10-25
Accepted
2018-10-25 14:33:57
Documents
10
Effectiveness Date
2018-10-25

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS defa14a102518_chinapharma.htm DEFA14A 82450
2 GRAPHIC img_001.jpg GRAPHIC 1959
3 GRAPHIC img_002.jpg GRAPHIC 2487
4 GRAPHIC img_003.jpg GRAPHIC 2426
5 GRAPHIC img_004.jpg GRAPHIC 2124
6 GRAPHIC img_009.jpg GRAPHIC 9024
7 GRAPHIC img_005.jpg GRAPHIC 2194
8 GRAPHIC img_006.jpg GRAPHIC 1732
9 GRAPHIC img_007.jpg GRAPHIC 1563
10 GRAPHIC img_008.jpg GRAPHIC 2285
  Complete submission text file 0001213900-18-014461.txt   120532
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1230
Type: DEFA14A | Act: 34 | File No.: 001-34471 | Film No.: 181138616
SIC: 2834 Pharmaceutical Preparations